The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A Bayesian neural network method for adverse drug reaction signal generation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction to the theory of neural computation
(1994) · Neural Networks · doi:10.1016/0893-6080(94)90014-0 · Cited by 6,401
Bayesian Networks for Data Mining
Heckerman, D. (1997) · Data Mining and Knowledge Discovery · doi:10.1023/a:1009730122752 · Cited by 630
Introduction to neural networks
Cross, S. S., Harrison, R. F., & Kennedy, R. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91746-2 · Cited by 615
Principles of Signal Detection in Pharmacovigilance
Meyboom, R. H. B., Egberts, A. C. G., Edwards, I. R., Hekster, Y. A., de Koning, F. H. P., & Gribnau, F. W. J. (1997) · Drug Safety · doi:10.2165/00002018-199716060-00002 · Cited by 239
Self-citationThe Use of a Bayesian Neural Network Model for Classification Tasks
Holst, A. G. (1997) · Cited by 43
Cited by
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
Self-citationSalem, J.-E., Manouchehri, A., Moey, M., Lebrun-Vignes, B., Bastarache, L., Pariente, A., Gobert, A., Spano, J.-P., Balko, J. M., Bonaca, M. P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30608-9 · Cited by 1,271
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Sakaeda, T., Tamon, A., Kadoyama, K., & Okuno, Y. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6048 · Cited by 1,048
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
Self-citationDumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
VigiBase, the WHO Global ICSR Database System: Basic Facts
Lindquist, M. (2008) · Drug Information Journal · doi:10.1177/009286150804200501 · Cited by 587
Self-citationBig data for cyber physical systems in industry 4.0: a survey
Xu, L. D., & Duan, L. (2019) · Enterprise Information Systems · doi:10.1080/17517575.2018.1442934 · Cited by 526
Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.50 · Cited by 393
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Self-citationUnderstanding vaccine safety information from the Vaccine Adverse Event Reporting System
VARRICCHIO, F., ISKANDER, J., DESTEFANO, F., BALL, R., PLESS, R., BRAUN, M. M., & CHEN, R. T. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00002 · Cited by 380
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
Johnson, D. B., Manouchehri, A., Haugh, A. M., Quach, H. T., Balko, J. M., Lebrun-Vignes, B., Mammen, A., Moslehi, J. J., & Salem, J.-E. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0617-x · Cited by 366
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01423-7 · Cited by 351
Self-citationShrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
Norén, G. N., Hopstadius, J., & Bate, A. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280211403604 · Cited by 336
Self-citationCase-non-case studies: principle, methods, bias and interpretation
Faillie, J.-L. (2019) · Therapies · doi:10.1016/j.therap.2019.01.006 · Cited by 336
The General Practice Research Database: Role in Pharmacovigilance
Wood, L., & Martinez, C. (2004) · Drug Safety · doi:10.2165/00002018-200427120-00004 · Cited by 331
Clarification of Terminology in Drug Safety
Aronson, J. K., & Ferner, R. E. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00003 · Cited by 328
Liu, M., Wu, Y., Chen, Y., Sun, J., Zhao, Z., Chen, X.-W., Matheny, M. E., & Xu, H. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000699 · Cited by 289
Noguchi, Y., Tachi, T., & Teramachi, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab347 · Cited by 285
The role of data mining in pharmacovigilance
Hauben, M., Madigan, D., Gerrits, C. M., Walsh, L., & Van Puijenbroek, E. P. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.5.929 · Cited by 276
Pariente, A., Gregoire, F., Fourrier-Reglat, A., Haramburu, F., & Moore, N. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00007 · Cited by 268
Cardiovascular Toxicities Associated With Ibrutinib
Salem, J.-E., Manouchehri, A., Bretagne, M., Lebrun-Vignes, B., Groarke, J. D., Johnson, D. B., Yang, T., Reddy, N. M., Funck-Brentano, C., Brown, J. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.056 · Cited by 266
Novel Statistical Tools for Monitoring the Safety of Marketed Drugs
Almenoff, J. S., Pattishall, E. N., Gibbs, T. G., DuMouchel, W., Evans, S. J. W., & Yuen, N. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100258 · Cited by 266
Business Intelligence for Enterprise Systems: A Survey
Duan, L., & Xu, L. D. (2012) · IEEE Transactions on Industrial Informatics · doi:10.1109/tii.2012.2188804 · Cited by 254
Liu, L., Chen, J., Wang, L., Chen, C., & Chen, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1043789 · Cited by 258
Computational Health Informatics in the Big Data Age: A Survey
Fang, R., Pouyanfar, S., Yang, Y., Chen, S.-C., & Iyengar, S. S. (2017) · ACM Computing Surveys · doi:10.1145/2932707 · Cited by 210
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1323057 · Cited by 224
Decision support methods for the detection of adverse events in post-marketing data
Hauben, M., & Bate, A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.012 · Cited by 163
Self-citationNguyen, L. S., Cooper, L. T., Kerneis, M., Funck-Brentano, C., Silvain, J., Brechot, N., Hekimian, G., Ammirati, E., Ben M’Barek, B., Redheuil, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27631-8 · Cited by 136
Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510703 · Cited by 134
Learning for Personalized Medicine: A Comprehensive Review From a Deep Learning Perspective
Zhang, S., Bamakan, S. M. H., Qu, Q., & Li, S. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2018.2864254 · Cited by 125
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Kaur, R., Dutta, S., Charan, J., Bhardwaj, P., Tandon, A., Yadav, D., Islam, S., & Haque, M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s324349 · Cited by 125
Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E., & Gastaldon, C. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.23385 · Cited by 107
Chiappini, S., Vickers-Smith, R., Harris, D., Papanti Pelletier, G. D., Corkery, J. M., Guirguis, A., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Pharmaceuticals · doi:10.3390/ph16070994 · Cited by 78
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines
Dutta, S., Kaur, R., Charan, J., Bhardwaj, P., Ambwani, S. R., Babu, S., Goyal, J. P., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.21376 · Cited by 36
Lamotrigine and aseptic meningitis
Simms, K. M., Kortepeter, C., & Avigan, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31824c4634 · Cited by 31
Xiong, S., Gou, R., Liang, X., Wu, H., Qin, S., Li, B., Luo, C., & Chen, J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01594-7 · Cited by 26
Safety assessment of disulfiram: real-world adverse event analysis based on FAERS database
Luo, J., Zeng, Y., Chen, Z., Luo, Y., Shi, L., & Zhou, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1498204 · Cited by 9
Metadata
- Authors
- Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1998-07-06
- Volume
- 54
- Issue
- 4
- Pages
- 315-321
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2015487160
- Cited by
- 1,476
- References
- 5
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.